Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosuppressant therapy.

P Katz

    Advances in Internal Medicine
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    This chapter reviews current and emerging immunosuppressant agents, highlighting their significant toxicity. Careful patient-centered decisions are crucial when balancing treatment benefits against risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    In-person versus virtual administration of the American College of Rheumatology gold standard cognitive battery in systemic lupus erythematosus: Are they interchangeable?

    Lupus·2023
    Same author

    Metabolic and Renal Effects of Mammalian Target of Rapamycin Inhibitors Treatment After Liver Transplantation: Real-Life Single-Center Experience.

    Transplantation proceedings·2020
    Same author

    Cerebral venous thrombosis and submandibular lithotripsy: A case report.

    Revue neurologique·2020
    Same author

    Long-Term Effects of Pregnancy on Renal Graft Function in Women After Kidney Transplantation Compared With Matched Controls.

    Transplantation proceedings·2018
    Same author

    Letter: complex interplay between obesity and Clostridium difficile infection-authors' reply.

    Alimentary pharmacology & therapeutics·2017
    Same author

    Who receives contraception counseling when starting new lupus medications? The potential roles of race, ethnicity, disease activity, and quality of communication.

    Lupus·2015
    Same journal

    Nutrition and nutritional diseases in the Orient.

    Advances in internal medicine·2010
    Same journal

    Nutritional requirements in disease.

    Advances in internal medicine·2010
    Same journal

    Problem of the rhesus antigen in medicine.

    Advances in internal medicine·2010
    Same journal

    Penicillin treatment of subacute bacterial endocarditis.

    Advances in internal medicine·2010
    Same journal

    Physiologic and medical aspects of aviation and deep sea diving.

    Advances in internal medicine·2010
    Same journal

    Progress in the development of insecticides for prevention of insect-borne diseases.

    Advances in internal medicine·2010
    See all related articles

    Area of Science:

    • Pharmacology and Immunology
    • Clinical Therapeutics

    Background:

    • Immunosuppressant agents are vital in managing various diseases.
    • Current therapies face challenges due to significant toxicity.
    • Informed decision-making is essential for effective immunosuppression.

    Purpose of the Study:

    • To discuss major immunosuppressant agents currently in use.
    • To explore agents with potential future applications.
    • To provide practical and theoretical importance for physicians.

    Main Methods:

    • Review of major immunosuppressant agents.
    • Discussion of practical and theoretical importance.
    • Analysis of agent toxicity and therapeutic limitations.

    Main Results:

    Related Experiment Videos

    • All discussed immunosuppressive therapies exhibit significant toxicity.
    • Therapeutic decisions require careful consideration of risks and benefits.
    • Lack of well-controlled trials complicates treatment choices for some conditions.

    Conclusions:

    • Physicians must involve patients and families in treatment decisions.
    • Balancing adverse effects against withholding treatment is critical.
    • Future research should focus on developing less toxic immunosuppressants.